Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (10)

2024

  1. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis

    JHEP Reports, Vol. 6, Núm. 8

2023

  1. Loss of liver function in chronic liver disease: An identity crisis

    Journal of Hepatology, Vol. 78, Núm. 2, pp. 401-414

2022

  1. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

2021

  1. Armcx3 mediates susceptibility to hepatic tumorigenesis promoted by dietary lipotoxicity

    Cancers, Vol. 13, Núm. 5, pp. 1-22

  2. The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation

    Nucleic Acids Research, Vol. 49, Núm. 15, pp. 8592-8609

2018

  1. Fibroblast growth factors 19 and 21 in acute liver damage

    Annals of Translational Medicine, Vol. 6, Núm. 12, pp. 257

2016

  1. Further evidence on the janus-faced nature of the epidermal growth factor receptor: From liver regeneration to hepatocarcinogenesis

    Hepatology, Vol. 63, Núm. 2, pp. 371-374

2015

  1. Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14

    Hepatology, Vol. 61, Núm. 5, pp. 1755-1757

  2. Oxidative Stress Mechanisms in Hepatocarcinogenesis

    STUDIES ON HEPATIC DISORDERS (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 449-477

2014

  1. Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis

    HEPATIC ONCOLOGY, Vol. 1, Núm. 2, pp. 241-252